Dr. Cavalcanti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
University of Texas Health Science Center at HoustonResidency, Psychiatry, 2023
Faculdade de Ciências Médicas de SantosClass of 2014
Certifications & Licensure
MN State Medical License 2022 - 2025
Publications & Presentations
PubMed
- 3 citationsEfficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis.Debora de A Simoes Moreira, Luís Eduardo Gauer, Guilherme Teixeira, Amanda Carolina Fonseca da Silva, Stefanie Cavalcanti
Journal of Affective Disorders. 2023-06-01 - 1 citationsA Case of Tachyphylaxis After Long-Term Intravenous Racemic Ketamine for Treatment-Resistant Depression.Stefanie Cavalcanti, Olga A Lopez, Simon Kung, Jennifer L Vande Voort, Kristin Somers
Journal of Clinical Psychopharmacology. 2024-03-09 - The Use of Ketamine for the Treatment of Anhedonia in Depression.Liliana Patarroyo-Rodriguez, Stefanie Cavalcanti, Jennifer L Vande Voort, Balwinder Singh
CNS Drugs. 2024-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
